Associate Professor, Neurology, Mayo Medical School
Neurology
Dr. Kevin B. Boylan, MD
|
|
Give Review
Doctor Kevin B. Boylan, MD works in the field of Neurology. He studied medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical college. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. He received 1 awards: "Regional Top Doctor". Doctor Kevin B. Boylan, MD is also a published doctor. He has 50 paper published. The most recent paper is: Unilateral pallidotomy for Parkinson's disease: comparison of outcome in younger versus elderly patients. Doctor Kevin B. Boylan, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells.
- ALS Biomarkers for Therapy Development: State of the Field & Future Directions.
- Chronic traumatic encephalopathy pathology in a neurodegenerative Disorders brain bank.
- Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS.
- Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neuroToxicity by inducing ER stress.
- Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS.
- Ataxin-2 as potential Disease modifier in C9ORF72 expansion carriers.
- TMEM106B protects C9ORF72 expansion carriers against frontotemporal Dementia.
- A Dominant Mutation in FBXO38 Causes Distal Spinal Muscular Atrophy with Calf Predominance.
- Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood.
- Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS.
- Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.
- Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosis.
- Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal Dementia.
- Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.
- Clinical and electrophysiologic variability in amyotrophic lateral sclerosis within a kindred harboring the C9ORF72 repeat expansion.
- Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS.
- Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
- TARDBP mutations in Parkinson's Disease.
- Length of normal alleles of C9ORF72 GGGGCC repeat do not influence Disease phenotype.
- Phosphorylated neurofilament heavy subunit (pNF-H) in Peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
- Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS.
- Defining normal duration for afterDischarges with repetitive nerve stimulation: a pilot study.
- Total laryngectomy in patients with advanced bulbar symptoms of amyotrophic lateral sclerosis.
- Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.
- Utility of subcutaneous fat aspiration for diagnosing amyloidosis in patients with isolated peripheral Neuropathy.
- DNA length polymorphism 5' to the myelin basic protein gene is associated with multiple sclerosis.
- CMT1A duplication analysis in the diagnostic evaluation of patients with peripheral Neuropathy.
- Persistent Dystonia associated with buspirone.
- Autosomal dominant distal spinal Muscular atrophy in four generations.
- Progressive Dystonia following resuscitation from cardiac arrest.
- Werdnig-Hoffmann Disease and chronic distal spinal muscular atrophy with apparent autosomal dominant inheritance.
- Characterization of cDNA and genomic DNA encoding SERCA1, the Ca(2+)-ATPase of human fast-twitch skeletal muscle sarcoplasmic reticulum, and its elimination as a candi...
- A yeast functional screen predicts new candidate ALS Disease genes.
- Conjugal amyotrophic lateral sclerosis: report of a young married couple.
- Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.
- Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice.
- Ataxin-2 repeat-length variation and neurodegeneration.
- Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.
- Characterization of DCTN1 genetic variability in neurodegeneration.
- Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ...
- Subcutaneous IGF-1 is not beneficial in 2-year ALS trial.
- Novel p.Ile151Val mutation in VCP in a patient of African American descent with sporadic ALS.
- De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis.
- A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.
- Unilateral pallidotomy for Parkinson's Disease: comparison of outcome in younger versus elderly patients.
- Aprataxin (APTX) gene mutations resembling multiple system atrophy.
- Characterization of frontotemporal Dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72.
Schools
University Of California San Francisco School Of Medicine
Johns Hopkins Hospital
University Ca Sf Med Center
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
Conditions Treated
- Anterior Horn Disease
- Ataxia
- Autonomic Disorders
- Brachial Plexus Palsy
- View All
Doctors Specialties
- Clinical Neurophysiology
- Neurology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Johns Hopkins University -
UCSF Medical Center -
University of California San Francisco School of Medicine
Hospital
-
Mayo Clinic - Jacksonville, Florida
Drug Facts
| NPI NUMBER | 1750370193 | |
| NPPES Provider LastName | BOYLAN | |
| NPPES Provider FirstName | KEVIN | |
| NPPES Provider ZIPCode | 322241865 | |
| NPPES Provider State | FL | |
| Specialty Description | Neurology | |
| Total Claim Count | 293.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1750370193 |
| Last Name Of The Provider | BOYLAN |
| First Name Of The Provider | KEVIN |
| View All |
Similar Doctors
|
|
Dr. John G. Boughey, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arastoo T. Nabizadeh-Eraghi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward S. Urban, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan R. Berger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Georgia Gianakakos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donna L. Hill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elliot L. Dimberg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christian J. Burrell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen D. Kennelly, MD
This Doctor is OpenDoctor Recommended.
|